CURRICULUM VITAE. Suzane Silbert

Size: px
Start display at page:

Download "CURRICULUM VITAE. Suzane Silbert"

Transcription

1 CURRICULUM VITAE Suzane Silbert, PhD 1. PERSONAL DATA Name: Suzane Silbert Sex: Female Date of Birth: October 27, 1968 Place of Birth: Porto Alegre, Brazil Marital Status: Married addresses: Present Address: Esoteric Testing Laboratory Clinical Lab/Pathology Department Tampa General Hospital One Tampa General Circle Tampa, Florida EDUCATION Biological Sciences: Pontifícia Universidade Católica do Rio Grande do Sul. Porto Alegre, RS, Brazil. From: 1986 to Master Degree: Thesis: Evaluation of the Antimicrobial Susceptibility and Molecular Typing of Pseudomonas aeruginosa isolated from CF patients. [Avaliação do Perfil de Sensibilidade a Antimicrobianos e Tipagem Molecular de Pseudomonas aeruginosa isoladas de pacientes portadores de Fibrose Cística]. Infectious and Parasitologic Diseases Program. Federal University of São Paulo. São Paulo, SP, Brazil. From: 1997 to Ph.D Degree: Thesis: Molecular Typing of Non-Fermentative Gram-Negative Bacilli: Applicability of Different Techniques. [Tipagem Molecular de Bacilos Gram-Negativos Não-Fermentadores: Comparação e Aplicabilidade de Diferentes Técnicas]. Infectious and Parasitologic Diseases Program. Federal University of São Paulo. São Paulo, SP, Brazil. From: 2000 to PROFESSIONAL TITLES AND LICENSES: Certified as a Specialist in Microbiology and Molecular Biology: Conselho Regional de Biologia 1 Região (Brazilian Biology Board), Certified as a Medical Technologist: Board of Directors, American Medical Technologists, AMT, ID Number: Certified as a Clinical Laboratory Technologist in Microbiology: Florida Board of Clinical Laboratory Personnel Licensure, License Number: TN

2 4.1. POSITIONS AND EMPLOYMENT Microbiologist of the Clinical Microbiology Laboratory Pathology Department - Hospital de Clínicas de Porto Alegre Porto Alegre, RS, Brazil. September 1991 to June 1997 Microbiologist of the Sexual Transmitted Diseases Laboratory Pregnant Women HIV Clinic - Federal University of São Paulo EPM São Paulo, SP, Brazil. October 1997 to March 1999 Supervisor of the Special Clinical Microbiology Laboratory Infectious Diseases Division - Federal University of Sao Paulo EPM São Paulo, SP, Brazil. June 2000 to March 2004 Lab Technical Coordinator Department of Clinical Pathology Albert Einstein Hospital (Certified by Joint Commission International) São Paulo, SP, Brazil. March 2004 to June 2007 Molecular Typing Lab Section Coordinator Infectious Diseases Division - Federal University of Sao Paulo EPM São Paulo, SP, Brazil. June 2000 to August 2007 Clinical Microbiologist Investigator Infectious Disease Section Bay Pines VA Healthcare System VHCS Bay Pines, FL. USA. November 2007 to May 2009 Clinical Scientist Esoteric Testing Laboratory - Clinical Lab/Pathology Department Tampa General Hospital. June 2009 to present 4.2. PROFESSIONAL TRAINING Genetic Department Federal University of Rio Grande do Sul Porto Alegre, RS, Brazil. August 1986 to July 1987 Clinical Microbiology Laboratory Clinical Pathology Department - Hospital de Clínicas de Porto Alegre Porto Alegre, RS, Brazil. April 1988 to May 1991 Micology Laboratory Dermatology Service - Santa Casa de Misericórdia do Rio de Janeiro Rio de Janeiro, RJ, Brazil. June to August 1991 Microbiology Laboratories Royal Brompton Hospital and Central Public Health Laboratory London, UK. October 1992 Laboratory of Hospital Infection Central Public Health Laboratory London, UK. March

3 Molecular Epidemiology and Fungus Testing Lab Pathology Department - University of Iowa Hospitals and Clinics Iowa City, IA, USA. April 1999 to May PEER-REVIEWED PUBLICATIONS 5.1. Silbert, S, Rosa, D, Matte, U, Goldim, JR, Barcellos, S, Procianoy, R. Staphylococcus sp. coagulase negative from blood cultures of newborn patients: infection versus contamination. Jornal de Pediatria. May, E. Sprinz, R.Mallman, S.Barcellos, S.Silbert, G.Schestatsky and Bem David. Aids-related cryptosporidial diarrhoea: an open study with roxithromycin. Journal of Antimicrobial Chemotherapy. 41, Suppl.B, Roland, RK; Mendes, RE; Silbert, S; Bolsoni, AP. Sader, HS. In vitro Antimicrobial Activity of Piperacillin/Tazobactam in Comparison With Other Broad Spectrum ß-Lactams. The Brazilian Journal of Infectious Diseases. 4 (5): Silbert, S.; Barth AL; Sader, HS. Heterogeneity of Pseudomonas aeruginosa in Brazilian Cystic Fibrosis Patients. Journal of Clinical Microbiology. 39 (11): Cereda, R.F.; Gales, AC; Silbert, S; Jones, RN; Sader, HS. Molecular Typing and Antimicrobial Susceptibility of Vancomycin-Resistant Enterococcus faecium (VRE) in Brazil. Infection Control Hospital Epidemiology. 23(1): Sejas, LM; Silbert, S; Reis, AO; Sader, HS. Evaluation of the quality of the antimicrobial agents disks used in disk-diffusion tests commercially available in Brazil. Jornal Brasileiro de Patologia. 39 (1): 27-35, Gales, AC; Menezes, LC; Silbert, S; Sader, HS. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo- -lactamase. Journal of Antimicrobial Chemotherapy. 52: , Silbert, S; Boyken, L; Hollis, RJ; Pfaller, MA. Improving Typeability of Multiple Bacterial Species Using Pulsed-Field Gel Electrophoresis and Thiourea. Diagnostic Microbiology and Infectious Diseases. 47 (4): , Castanheira, M; Jones, RN; Silbert, S; Brandileone, MCC; Sader, HS. Typing and Molecular Characterization of Streptococcus pneumoniae with Reduced Susceptibility to Cefotaxime Isolated in Latin America. Microbial Drug Resistance Mechanisms Epidemiology and Disease. 9 (4): , Tosin, I; Silbert, S; Sader, HS. The use of Molecular Typing to Evaluate the Dissemination of Antimicrobial Resistance among Gram-negative Rods in Brazilian Hospitals. The Brazilian Journal of Infectious Diseases. 7(6): , Cordeiro, JCR; Silbert, S; Reis, AO; Sader, HS. Inter-Hospital Dissemination of Glycopeptide Resistant Enterococcus faecalis in Brazil. Clinical Microbiology and Infection. 10(3): , Silbert, S.; Pfaller MA; Hollis RJ; Barth AL; Sader HS. Evaluation of Three Molecular Typing Techniques for Nonfermentative Gram-Negative Bacilli. Infection Control and Hospital Epidemiology. 25(10): , Barbosa D; Lima L; Silbert, S.; Sader HS; Cendoroglo M; Draibe S; Camargo L; Vianna L; A. Belasco; Sesso R. Evaluation of the prevalence and risk factors for colonization by vancomycin-resistant Enterococcus among patients on dialysis. Am Journal of Kidney Diseases. 44(2): ,

4 5.14. Tognin MC; Andrade SS; Silbert, S.; Gales AC; Jones RN; Sader HS. Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program. International Journal of Infectious Diseases.8: , Sader HS; Reis AO; Silbert, S; Gales AC. IMPs, VIMs and SPMs: the diversity of metallo-betalactamases in a Brazilian hospital. Clinical Microbiology and Infection. 11: 73-76, Ribeiro J; Mendes RE; Domingos R; França E; Silbert, S; Jones RN; Sader HS. Microbiological and Epidemiological Characterization of Imipenem-Resistant Pseudomonas aeruginosa Strains from a Brazilian Tertiary Hospital: Report from the SENTRY Antimicrobial Surveillance Program. Journal of Chemotherapy.18: , Freitas, MC; Pacheco-Silva, A; Barbosa D; Silbert, S; Sader HS; Sesso R; Camargo, LFA. Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients. BMC Infectious Diseases (Online). 6: 133, Tognin MC; Gales AC; Penteado A; Silbert, S; Sader HS. Dissemination of IMP-1 Metallo-Beta- Lactamase-Producing Acinetobacter spp. in a Brazilian Teaching Hospital. Infection Control and Hospital Epidemiology. 27 (7): , Zavascki, A., Soares, F., Superti, S., Silbert, S., Silva, F. M., Barth AL. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa. International Journal of Antimicrobial Agents, 30: , R. Sitnik, H. Sette Jr., R.A.F. Santana, L.C. Menezes, C.H.N. Graça, G.T.F. Dastoli, S. Silbert, J.R.R. Pinho. Hepatitis B virus genotype E detected in Brazil in an African patient who is a frequent traveler. Brazilian Journal of Medical and Biological Research, 40 (12): , Almeida, M. T. G., Rubio, F. G., Garcia, D. O., Pavarino-Bertelli, E. C., Rossit, A. R. B., Bando, S. Y., Silbert, S., Goloni-Bertollo, E. M., Soares, M. M. C. N., Martinez, M. B. Genetic relatedness among clinical strains of Stenotrophomonas maltophilia in tertiary care hospital settings in Sao Paulo State, Brazil. Brazilian Journal of Microbiology,38: , d'azevedo, P. A., Furtado, G., Medeiros EAS, Santiago, K. A., Silbert, S, Pignatari ACC. Molecular characterization of vancomycin-resistant Enterococci strain eight years apart from its first isolation in São Paulo, Brazil. Journal of the São Paulo Institute of Tropical Medicine [Revista do Instituto de Medicina Tropical de São Paulo], 50: , Silva, F.M., Carmo, M.S., Silbert, S., Gales, A.C. SPM-1-Producing Pseudomonas aeruginosa: Analysis of the Ancestor Relationship Using Multilocus Sequence Typing, Pulsed-Field Gel Electrophoresis, and Automated Ribotyping. Microbial Drug Resistance, 17 (2): , Monteiro, J., Widen, R., Kubasek, C., Pignatari, A.C.C., Silbert, S. Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother, doi: /jac/dkr563. Jan, BOOK CHAPTER 6.1. Sitnik, R; Silbert, S; Pinho, JRR. Viral Resistance: Genotyping, Phenotyping and Virtual Phenotyping. [Resistência Viral: Genotipagem, Fenotipagm e Fenotipagem Virtual]. In: Roberto Focaccia. (Org.) VERONESI - Tratado de Infectologia. 3 ed. São Paulo: Atheneu, 2005, 1:

5 7. AD HOC REVIEWER 7.1. Diagnostic Microbiology and Infectious Diseases. Since: Infection Control and Hospital Epidemiology. Since: American Journal of Infection Control. Since: Brazilian Journal of Microbiology. Since: Journal of Antimicrobial Chemotherapy. Since: Journal of Medical Microbiology. Since: Journal of Virological Methods. Since: Journal of Cystic Fibrosis. Since: Molecular Biology Reports. Since: INVITED LECTURES, COURSES MINISTRATED AND CONFERENCES PRESENTATION Total: POSTER PRESENTATIONS IN SCIENTIFIC MEETINGS Total: SCIENTIFIC SOCIETY MEMBERSHIP American Society for Microbiology: Membership # Since: PARTICIPATION IN MEETINGS, SYMPOSIUMS AND COURSES Sixty-three participations in meetings, symposiums and courses, most of them about Clinical Microbiology and Molecular Biology. Updated: Dec,

Antimicrobial Activity of Linezolid Against Gram-Positive Cocci Isolated in Brazil

Antimicrobial Activity of Linezolid Against Gram-Positive Cocci Isolated in Brazil BJID 2001; 5 (August) 171 Antimicrobial Activity of Linezolid Against Gram-Positive Cocci Isolated in Brazil Helio S. Sader, Ana C. Gales and Ronald N. Jones Special Clinical Microbiology Laboratory, Division

More information

Intrinsic, implied and default resistance

Intrinsic, implied and default resistance Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been

More information

A snapshot of polymyxin use around the world South America

A snapshot of polymyxin use around the world South America A snapshot of polymyxin use around the world South America Alexandre P. Zavascki Infectious Diseases Service, Hospital de Clínicas de Porto Alegre Medical School, Federal University of Rio Grande do Sul

More information

DOI: /

DOI: / Jornal Brasileiro de Patologia e Medicina Laboratorial ISSN: 1678-4774 Sociedade Brasileira de Patologia Clínica; Sociedade Brasileira de Patologia; Sociedade Brasileira de Citopatologia Paula, Milena

More information

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs Patrick R. Murray, PhD Senior Director, WW Scientific Affairs 2017 BD. BD, the BD Logo and all other trademarks

More information

BJID 2001; 5 (February) 21

BJID 2001; 5 (February) 21 BJID 2001; 5 (February) 21 Antimicrobial Susceptibility of Quinupristin/Dalfopristin Tested Against Gram-Positive Cocci From Latin America: Results from the Global SMART (GSMART) Surveillance Study Helio

More information

C&W Three-Year Cumulative Antibiogram January 2013 December 2015

C&W Three-Year Cumulative Antibiogram January 2013 December 2015 C&W Three-Year Cumulative Antibiogram January 213 December 215 Division of Microbiology, Virology & Infection Control Department of Pathology & Laboratory Medicine Contents Comments and Limitations...

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007

More information

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine 2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose

More information

The Challenges of Antimicrobial Resistance in Brazil

The Challenges of Antimicrobial Resistance in Brazil ANTIMICROBIAL RESISTANCE George M. Eliopoulos, Section Editor INVITED ARTICLE The Challenges of Antimicrobial Resistance in Brazil Flávia Rossi Pathology Department, DLC_LIM 03, Hospital das Clínicas da

More information

Antimicrobial Resistance Strains

Antimicrobial Resistance Strains Antimicrobial Resistance Strains Microbiologics offers a wide range of strains with characterized antimicrobial resistance mechanisms including: Extended-Spectrum β-lactamases (ESBLs) Carbapenamases Vancomycin-Resistant

More information

Original Articles. K A M S W Gunarathne 1, M Akbar 2, K Karunarathne 3, JRS de Silva 4. Sri Lanka Journal of Child Health, 2011; 40(4):

Original Articles. K A M S W Gunarathne 1, M Akbar 2, K Karunarathne 3, JRS de Silva 4. Sri Lanka Journal of Child Health, 2011; 40(4): Original Articles Analysis of blood/tracheal culture results to assess common pathogens and pattern of antibiotic resistance at medical intensive care unit, Lady Ridgeway Hospital for Children K A M S

More information

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital 2010 ANTIBIOGRAM University of Alberta Hospital and the Stollery Children s Hospital Medical Microbiology Department of Laboratory Medicine and Pathology Table of Contents Page Introduction..... 2 Antibiogram

More information

DEPARTMENT OF MEDICAL MICROBIOLOGY

DEPARTMENT OF MEDICAL MICROBIOLOGY 1. Title of Subject: Tumor viruses and oncogenes DEPARTMENT OF MEDICAL MICROBIOLOGY semester: 2 nd Coordinator: Dr. György Veress Instructors: Dr. György Veress Entrance conditions: Final exam from Medical

More information

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase

More information

HEALTHCARE-ACQUIRED INFECTIONS AND ANTIMICROBIAL RESISTANCE

HEALTHCARE-ACQUIRED INFECTIONS AND ANTIMICROBIAL RESISTANCE Universidade de São Paulo Departamento de Moléstias Infecciosas e Parasitárias HEALTHCARE-ACQUIRED INFECTIONS AND ANTIMICROBIAL RESISTANCE Anna S. Levin 4 main lines! Epidemiology of HAS and resistance!

More information

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection Surveillance, Outbreaks, and Reportable Diseases, Oh My! Assisted Living Facility, Nursing Home and Surveyor Infection Prevention Training February 2015 A.C. Burke, MA, CIC Health Care-Associated Infection

More information

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical

More information

Summary of the latest data on antibiotic resistance in the European Union

Summary of the latest data on antibiotic resistance in the European Union Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network

More information

RCH antibiotic susceptibility data

RCH antibiotic susceptibility data RCH antibiotic susceptibility data The following represent RCH antibiotic susceptibility data from 2008. This data is used to inform antibiotic guidelines used at RCH. The data includes all microbiological

More information

International Journal of Pharma and Bio Sciences ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI ABSTRACT

International Journal of Pharma and Bio Sciences ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI ABSTRACT Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI * PRABHAKAR C MAILAPUR, DEEPA

More information

EARS Net Report, Quarter

EARS Net Report, Quarter EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased

More information

Antimicrobial activity of ceftobiprole against Gram-negative and Gram-positive pathogens: results from INVITA-A-CEFTO Brazilian study

Antimicrobial activity of ceftobiprole against Gram-negative and Gram-positive pathogens: results from INVITA-A-CEFTO Brazilian study Antimicrobial activity of ceftobiprole against Gram-negative and Gram-positive pathogens: results from INVITA-A-CEFTO Brazilian study ORIGINAL ARTICLE ABSTRACT Ceftobiprole is a broad-spectrum cephalosporin

More information

Report on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli"

Report on the APUA Educational Symposium: Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli Preserving the Power of Antibiotics Report on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli" Held on Thursday, September 30, 2004 in Boston, MA Preceding

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXVII NUMBER 6 July 2012 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine B. Dowell SM, MLS (ASCP); Sarah K. Parker, MD; James K. Todd, MD Each year the Children s Hospital Colorado

More information

Dalbavancin, enterococci, Gram-positive cocci, Latin America, staphylococci, streptococci

Dalbavancin, enterococci, Gram-positive cocci, Latin America, staphylococci, streptococci ORIGINAL ARTICLE 10.1111/j.1469-0691.2004.01051.x Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres A. C. Gales 1, H. S. Sader 1,2

More information

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them? Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them? Roberta B. Carey, PhD Centers for Disease Control and Prevention Division of Healthcare Quality Promotion Why worry? MDROs Clinical

More information

UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients

UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients Background/methods: UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients This guideline establishes evidence-based consensus standards for management

More information

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University

More information

2 P. aeruginosa: Resistance and Molecular Typing BJI 2002; 6 (February) macrorestriction analysis by pulsed field gel electrophoresis, have been succe

2 P. aeruginosa: Resistance and Molecular Typing BJI 2002; 6 (February) macrorestriction analysis by pulsed field gel electrophoresis, have been succe BJI 2002; 6 (February) 1 Antibiotic Resistance and Molecular Typing of Pseudomonas aeruginosa: Focus on Imipenem Ana Lúcia Peixoto de Freitas and Afonso Luis Barth Federal University of Rio Grande do Sul,

More information

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How

More information

ORIGINAL ARTICLE. influenzae and Moraxella catarrhalis to antimicrobial agents used to treat respiratory tract infections.

ORIGINAL ARTICLE. influenzae and Moraxella catarrhalis to antimicrobial agents used to treat respiratory tract infections. ORIGINAL ARTICLE Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997 98 I. A. Critchley 1, C. Thornsberry

More information

Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities

Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities REVIEW Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities Fiona Walsh Department of Clinical Microbiology, Trinity College Dublin, Dublin, Ireland

More information

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital 2009 ANTIBIOGRAM University of Alberta Hospital and the Stollery Childrens Hospital Division of Medical Microbiology Department of Laboratory Medicine and Pathology 2 Table of Contents Page Introduction.....

More information

Multi-Drug Resistant Organisms (MDRO)

Multi-Drug Resistant Organisms (MDRO) Multi-Drug Resistant Organisms (MDRO) 2016 What are MDROs? Multi-drug resistant organisms, or MDROs, are bacteria resistant to current antibiotic therapy and therefore difficult to treat. MDROs can cause

More information

Microbiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR:

Microbiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR: Microbiology Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention June 2017 MeshHp (VS) Medical Care Center Dr. Eberhard & Partner Dortmund (ÜBAG) www.labmed.de MVZ Dr. Eberhard &

More information

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant

More information

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic

More information

RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR

RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR Original article RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR R.Sujatha 1,Nidhi Pal 2, Deepak S 3 1. Professor & Head, Department

More information

RESISTANT PATHOGENS. John E. Mazuski, MD, PhD Professor of Surgery

RESISTANT PATHOGENS. John E. Mazuski, MD, PhD Professor of Surgery RESISTANT PATHOGENS John E. Mazuski, MD, PhD Professor of Surgery Disclosures Contracted Research: AstraZeneca, Bayer, Merck. Advisory Boards/Consultant: Allergan (Actavis, Forest Laboratories), AstraZeneca,

More information

Public Health Response to Emerging Resistance

Public Health Response to Emerging Resistance National Center for Emerging and Zoonotic Infectious Diseases Public Health Response to Emerging Resistance Alex Kallen, MD, MPH, FACP Lead Antimicrobial Resistance and Emerging Pathogens Team Prevention

More information

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems Micro 301 Antimicrobial Drugs 11/7/12 Significance of antimicrobial drugs Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems Definitions Antibiotic Selective

More information

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016) BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016) VA Palo Alto Health Care System April 14, 2017 Trisha Nakasone, PharmD, Pharmacy Service Russell Ryono, PharmD, Public Health Surveillance

More information

Tel: Fax:

Tel: Fax: CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.

More information

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016 Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate

More information

Trends in antimicrobial resistance among clinical isolates of enterococci in a Brazilian tertiary hospital: a 4-year study

Trends in antimicrobial resistance among clinical isolates of enterococci in a Brazilian tertiary hospital: a 4-year study Trends in antimicrobial resistance among clinical isolates of enterococci in a Brazilian tertiary hospital: a 4-year study Evolução da resistência aos antimicrobianos entre isolados clínicos de enterococos

More information

Antimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013

Antimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013 Antimicrobial Resistance Surveillance from sentinel public s, South Africa, 213 Authors: Olga Perovic 1,2, Melony Fortuin-de Smidt 1, and Verushka Chetty 1 1 National Institute for Communicable Diseases

More information

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

Major Article. Luciana Azevedo Callefi [1], Eduardo Alexandrino Servolo de Medeiros [1] and Guilherme Henrique Campos Furtado [1] INTRODUCTION METHODS

Major Article. Luciana Azevedo Callefi [1], Eduardo Alexandrino Servolo de Medeiros [1] and Guilherme Henrique Campos Furtado [1] INTRODUCTION METHODS Revista da Sociedade Brasileira de Medicina Tropical 46(1):45-49, Jan-Feb, 2013 http://dx.doi.org/10.1590/0037-868216622013 Major Article Impact of the introduction of an automated microbiologic system

More information

Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units

Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units NEW MICROBIOLOGICA, 34, 291-298, 2011 Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units Vladimíra Vojtová 1, Milan Kolář 2, Kristýna Hricová 2, Radek Uvízl 3, Jan Neiser

More information

Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital,

Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital, Original Article Vol. 28 No. 1 Surveillance of Antimicrobial Resistance:- Chaiwarith R, et al. 3 Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at

More information

Mechanism of antibiotic resistance

Mechanism of antibiotic resistance Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance

More information

Antimicrobial Stewardship:

Antimicrobial Stewardship: Antimicrobial Stewardship: Inpatient and Outpatient Elements Angela Perhac, PharmD afperhac@carilionclinic.org Disclosure I have no relevant finances to disclose. Objectives Review the core elements of

More information

Detecting / Reporting Resistance in Nonfastidious GNR Part #2. Janet A. Hindler, MCLS MT(ASCP)

Detecting / Reporting Resistance in Nonfastidious GNR Part #2. Janet A. Hindler, MCLS MT(ASCP) Detecting / Reporting Resistance in Nonfastidious GNR Part #2 Janet A. Hindler, MCLS MT(ASCP) Methods Described in CLSI M100-S21 for Testing non-enterobacteriaceae Organism Disk Diffusion MIC P. aeruginosa

More information

Human health impacts of antibiotic use in animal agriculture

Human health impacts of antibiotic use in animal agriculture Human health impacts of antibiotic use in animal agriculture Beliefs, opinions, and evidence Peter Davies BVSc, PhD College of Veterinary Medicine, University of Minnesota, USA Terminology Antibiotic Compound

More information

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS 1 2 Untoward Effects of Antibiotics Antibiotic resistance Adverse drug events (ADEs) Hypersensitivity/allergy Drug side effects

More information

CAVICIDE1. Technical Bulletin

CAVICIDE1. Technical Bulletin CAVICIDE1 Technical Bulletin CaviCide1 is a multi-purpose disinfectant intended for use in cleaning, decontaminating and disinfecting hard non-porous, inanimate surfaces and non-critical instruments in

More information

Hospital ID: 831. Bourguiba Hospital. Tertiary hospital

Hospital ID: 831. Bourguiba Hospital. Tertiary hospital Global Point Prevalence Survey of Antimicrobial Consumption and Resistance in hospitals worldwide Hospital ID: 831 Habib Bourguiba Hospital Tertiary hospital Tunisia Point Prevalence Survey Habib 2017

More information

Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium

Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium www.ivis.org Proceedings of the 19th American Academy of Veterinary Pharmacology and Therapeutics Biennial Symposium May 17-20, 2015 Fort Collins, CO, USA Reprinted in the IVIS website with the permission

More information

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production

More information

ESCHERICHIA COLI RESISTANCE AND GUT MICROBIOTA PROFILE IN PIGS RAISED WITH DIFFERENT ANTIMICROBIAL ADMINISTRATION IN FEED

ESCHERICHIA COLI RESISTANCE AND GUT MICROBIOTA PROFILE IN PIGS RAISED WITH DIFFERENT ANTIMICROBIAL ADMINISTRATION IN FEED ESCHERICHIA COLI RESISTANCE AND GUT MICROBIOTA PROFILE IN PIGS RAISED WITH DIFFERENT ANTIMICROBIAL ADMINISTRATION IN FEED Caroline Pissetti 1, Jalusa Deon Kich 2, Heather K. Allen 3, Claudia Navarrete

More information

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal Preventing Multi-Drug Resistant Organism (MDRO) Infections For National Patient Safety Goal 07.03.01 2009 Methicillin Resistant Staphlococcus aureus (MRSA) About 3-8% of the population at large is a carrier

More information

INTERNATIONAL SYMPOSIUM ON ANTIMICROBIAL RESISTANCE

INTERNATIONAL SYMPOSIUM ON ANTIMICROBIAL RESISTANCE INTERNATIONAL SYMPOSIUM ON ANTIMICROBIAL RESISTANCE Combating Bacterial Resistance: many sizes to fit all Santiago de Cali, March 7TH, 8TH, 9TH 2018 Intercontinental Hotel Academic Program "Gato de Tejada"

More information

Trends of 9,416 multidrug-resistant Gram-negative bacteria

Trends of 9,416 multidrug-resistant Gram-negative bacteria ORIGINAL ARTICLE Oliveira VDC et al. Trends of 9,416 multidrug-resistant Gram-negative bacteria Viviane Decicera Colombo Oliveira 1 *, Fernando Góngora Rubio 2, Margarete Teresa Gottardo Almeida 2, Mara

More information

Antimicrobial Susceptibility Testing: Advanced Course

Antimicrobial Susceptibility Testing: Advanced Course Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to

More information

Study of drug resistance pattern of principal ESBL producing urinary isolates in an urban hospital setting in Eastern India

Study of drug resistance pattern of principal ESBL producing urinary isolates in an urban hospital setting in Eastern India Research article Study of drug resistance pattern of principal ESBL producing urinary isolates in an urban hospital setting in Eastern India Mitali Chatterjee, 1 M. Banerjee, 1 S. Guha, 2 A.Lahiri, 3 K.Karak

More information

What s next in the antibiotic pipeline?

What s next in the antibiotic pipeline? What s next in the antibiotic pipeline? Jennifer Tieu, Pharm.D., BCPS Clinical Pearls OSHP Spring Meeting Mercy Hospital April 13, 2018 Objective 2 Describe the drug class and mechanism of action of antibiotics

More information

Antimicrobial Resistance and Prescribing

Antimicrobial Resistance and Prescribing Antimicrobial Resistance and Prescribing John Ferguson, Microbiology & Infectious Diseases, John Hunter Hospital, University of Newcastle, NSW, Australia M Med Part 1 updates UPNG 2017 Tw @mdjkf http://idmic.net

More information

Antimicrobial Cycling. Donald E Low University of Toronto

Antimicrobial Cycling. Donald E Low University of Toronto Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXXII NUMBER 6 September 2017 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Stacey Hamilton MT SM (ASCP), Samuel Dominguez MD PhD, Sarah Parker MD, and

More information

Drive More Efficient Clinical Action by Streamlining the Interpretation of Test Results

Drive More Efficient Clinical Action by Streamlining the Interpretation of Test Results White Paper: Templated Report Comments Drive More Efficient Clinical Action by Streamlining the Interpretation of Test Results Background The availability of rapid, multiplexed technologies for the comprehensive

More information

Testimony of the Natural Resources Defense Council on Senate Bill 785

Testimony of the Natural Resources Defense Council on Senate Bill 785 Testimony of the Natural Resources Defense Council on Senate Bill 785 Senate Committee on Healthcare March 16, 2017 Position: Support with -1 amendments I thank you for the opportunity to address the senate

More information

Decrease of vancomycin resistance in Enterococcus faecium from bloodstream infections in

Decrease of vancomycin resistance in Enterococcus faecium from bloodstream infections in AAC Accepted Manuscript Posted Online 30 March 2015 Antimicrob. Agents Chemother. doi:10.1128/aac.00513-15 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 Decrease of vancomycin

More information

Understanding the Hospital Antibiogram

Understanding the Hospital Antibiogram Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital

More information

Presenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update

Presenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update Emergence of invasive Carbapenem Resistant Enterobacteriaceae CRE infection at RCWMCH Ombeva Oliver Malande, Annerie du Plessis, Colleen Bamford, Brian Eley Presenter: Ombeva Malande Red Cross Children's

More information

New Drugs for Bad Bugs- Statewide Antibiogram

New Drugs for Bad Bugs- Statewide Antibiogram New Drugs for Bad Bugs- Statewide Antibiogram Felicia Matthews, Pharm.D., BCPS Senior Consultant, Pharmacy Specialty BE MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda

More information

ANTIBIOTIC STEWARDSHIP

ANTIBIOTIC STEWARDSHIP ANTIBIOTIC STEWARDSHIP S.A. Dehghan Manshadi M.D. Assistant Professor of Infectious Diseases and Tropical Medicine Tehran University of Medical Sciences Issues associated with use of antibiotics were recognized

More information

Resistance trends of Acinetobacter

Resistance trends of Acinetobacter International Journal of Infectious Diseases (2004) 8, 284 291 Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains:

More information

Service Delivery and Safety Department World Health Organization, Headquarters

Service Delivery and Safety Department World Health Organization, Headquarters Service Delivery and Safety Department World Health Organization, Headquarters WHO global (laboratory-based) survey on multidrug-resistant organisms (MDROs) in health care PROJECT SUMMARY Given the important

More information

Occurrence and the susceptibility to antimicrobial agents in Pseudomonas aeruginosa and Acinetobacter sp. at a tertiary hospital in southern Brazil

Occurrence and the susceptibility to antimicrobial agents in Pseudomonas aeruginosa and Acinetobacter sp. at a tertiary hospital in southern Brazil Revista da Sociedade Brasileira de Medicina Tropical 44(2):168-172, mar-abr, 2011 DOI: 10.1590/S0037-86822011005000015 Article/Artigo Occurrence and the susceptibility to antimicrobial agents in Pseudomonas

More information

Management of Hospital-acquired Pneumonia

Management of Hospital-acquired Pneumonia Management of Hospital-acquired Pneumonia Adel Alothman, MB, FRCPC, FACP Asst. Professor, COM, KSAU-HS Head, Infectious Diseases, Department of Medicine King Abdulaziz Medical City Riyadh Saudi Arabia

More information

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO) Multidrug Resistant Organisms (MDROs) Kasturi Shrestha, M.D. 05/11/2018 Objectives Define a multi-drug resistant organism (MDRO) Identify most challenging MDROs in healthcare Identify reasons for health

More information

Over the past several decades, the frequency of. Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years. Ronald N.

Over the past several decades, the frequency of. Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years. Ronald N. Resistance Patterns Among Nosocomial Pathogens* Trends Over the Past Few Years Ronald N. Jones, MD Multiple surveillance studies have demonstrated that resistance among prevalent pathogens is increasing

More information

Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana

Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana Beverly Egyir, PhD Noguchi Memorial Institute for Medical Research Bacteriology Department, University of Ghana Background

More information

INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS

INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS 1 Research Associate, Drug Utilisation Research Unit, Nelson Mandela University 2 Human Sciences Research Council,

More information

11/22/2016. Hospital-acquired Infections Update Disclosures. Outline. No conflicts of interest to disclose. Hot topics:

11/22/2016. Hospital-acquired Infections Update Disclosures. Outline. No conflicts of interest to disclose. Hot topics: Hospital-acquired Infections Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University

More information

Multi-drug resistant microorganisms

Multi-drug resistant microorganisms Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the

More information

Susceptibility Testing and Resistance Phenotypes Detection in Bacterial Pathogens Using the VITEK 2 System

Susceptibility Testing and Resistance Phenotypes Detection in Bacterial Pathogens Using the VITEK 2 System Polish Journal of Microbiology 2005, Vol. 54, No 4, 311 316 Susceptibility Testing and Resistance Phenotypes Detection in Bacterial Pathogens Using the VITEK 2 System EL BIETA STEFANIUK*, AGNIESZKA MRÓWKA

More information

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL ESBL- and carbapenemase-producing microorganisms; state of the art Laurent POIREL Medical and Molecular Microbiology Unit Dept of Medicine University of Fribourg Switzerland INSERM U914 «Emerging Resistance

More information

Regional Workshop on AMR in South East Asia Penang (Malaysia): March 2018

Regional Workshop on AMR in South East Asia Penang (Malaysia): March 2018 Regional Workshop on AMR in South East Asia Penang (Malaysia): 26-28 March 2018 Prof : Htay Htay Tin drhtayhtaytin@gmail.com DDG ( Laboratory) National Focal Point for AMR Ministry of Health and Sports

More information

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011 Antibiotic Resistance Antibiotic Resistance: A Growing Concern Judy Ptak RN MSN Infection Prevention Practitioner Dartmouth-Hitchcock Medical Center Lebanon, NH Occurs when a microorganism fails to respond

More information

PrevalenceofAntimicrobialResistanceamongGramNegativeIsolatesinanAdultIntensiveCareUnitataTertiaryCareCenterinSaudiArabia

PrevalenceofAntimicrobialResistanceamongGramNegativeIsolatesinanAdultIntensiveCareUnitataTertiaryCareCenterinSaudiArabia : K Interdisciplinary Volume 17 Issue 4 Version 1.0 Year 2017 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc. (USA) Online ISSN: 2249-4618 & Print ISSN:

More information

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria

More information

Antimicrobial stewardship: Quick, don t just do something! Stand there!

Antimicrobial stewardship: Quick, don t just do something! Stand there! Antimicrobial stewardship: Quick, don t just do something! Stand there! Stanley I. Martin, MD, FACP, FIDSA Director, Division of Infectious Diseases Director, Antimicrobial Stewardship Program Geisinger

More information

Metallo Beta Lactamase Producing Pseudomonas aeruginosa in a Tertiary Care Hospital

Metallo Beta Lactamase Producing Pseudomonas aeruginosa in a Tertiary Care Hospital International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 11 (2016) pp. 269-274 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.511.029

More information

Journal of Hospital Infection

Journal of Hospital Infection Journal of Hospital Infection 75 () 23 27 Available online at www.sciencedirect.com Journal of Hospital Infection journal homepage: www.elsevierhealth.com/journals/jhin Impact of hospital-wide infection

More information

Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16

Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16 Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16 These criteria are based on national and local susceptibility data as well as Infectious Disease Society of America

More information

OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS

OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS HTIDE CONFERENCE 2018 OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS FEDERICO PEA INSTITUTE OF CLINICAL PHARMACOLOGY DEPARTMENT OF MEDICINE, UNIVERSITY OF UDINE, ITALY SANTA

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXIX NUMBER 3 November 2014 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Marti Roe SM MLS (ASCP), Sarah Parker MD, Jason Child PharmD, and Samuel R.

More information